Our study developed an easy-to-use and reproducible platform with high-throughput drug screening, a 3D culture model and an in-vivo model for TED studies, which was based on a TED patient-derived OF-CL with proliferative and adipogenic properties and without severely perturbing genotype inheritance. Thyroid eye disease (TED), the most frequent orbital disease and the leading cause of proptosis in adults, is a debilitating, disfiguring, and even sight-threatening disease.[1] Drugs as alternative options are required for TED patients who need surgery to control orbital compression. Repurposing picropodophyllin as a potential thyroid eye disease treatment via delaying mitotic clonal expansion through a patient-derived preclinical platform The stromal vascular fraction (SVF) was isolated from the OAT of a 35-year-old female TED patient who underwent decompression surgery, and cultured in dishes for primary orbital fibroblasts (OFs). [Extracted from the article]